We are live on ! Find out more
PLSE icon

Pulse Biosciences
PLSE

51 hedge funds and large institutions have $30.3M invested in Pulse Biosciences in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 6

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

94% more capital invested

Capital invested by funds: $15.6M → $30.3M (+$14.7M)

9% more funds holding

Funds holding: 47 → 51 (+4)

1.05% more ownership

Funds ownership: 10.61% → 11.66% (+1.1%)

Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
27
Reduced
6
Closed
4
Calls
$394K
Puts
–
Net Calls
+$394K
Net Calls Change
+$133K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.46M
2
BlackRock
BlackRock
New York
+$1.31M
3
Northern Trust
Northern Trust
Illinois
+$938K
4
Squarepoint
Squarepoint
New York
+$390K
5
State Street
State Street
Massachusetts
+$374K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$90K
2
Victory Capital Management
Victory Capital Management
Texas
-$28K
3
UBS Group
UBS Group
Switzerland
-$23.3K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$20.3K
5
Citigroup
Citigroup
New York
-$12.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$106K +$58.7K +6,517 +180%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$105K -$18 -2 -0%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$103K – – –
AIG
29
American International Group
New York
$88K +$15.5K +1,723 +26%
Barclays
30
Barclays
United Kingdom
$79K +$34.7K +3,854 +103%
Osaic Holdings
31
Osaic Holdings
Arizona
$71K – – –
Deutsche Bank
32
Deutsche Bank
Germany
$70K +$25.8K +2,866 +75%
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
$70K +$61.8K +6,868 New
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$50K +$10.8K +1,203 +33%
TRCT
35
Tower Research Capital (TRC)
New York
$28K +$21.9K +2,427 +923%
Legal & General Group
36
Legal & General Group
United Kingdom
$22K +$3.23K +359 +20%
Citigroup
37
Citigroup
New York
$20K -$12.4K -1,372 -41%
Carson Wealth (CWM LLC)
38
Carson Wealth (CWM LLC)
Nebraska
$17K – – –
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$13.1K -$20.3K -2,250 -64%
Simplex Trading
40
Simplex Trading
Illinois
$12K +$10.9K +1,212 New
Fifth Third Bancorp
41
Fifth Third Bancorp
Ohio
$10K – – –
AIP
42
Ameritas Investment Partners
Nebraska
$8K – – –
SPIA
43
Steward Partners Investment Advisory
New York
$7K – – –
Group One Trading
44
Group One Trading
Illinois
$7K +$1.04K +116 +20%
Nisa Investment Advisors
45
Nisa Investment Advisors
Missouri
$5K – – –
PA
46
Parallel Advisors
California
$2K – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$1K -$2.04K -227 -67%
CP
48
Corbenic Partners
Pennsylvania
$1K – – –
WOC
49
West Oak Capital
California
$1K – – –
WIM
50
Westside Investment Management
California
$373 +$78K +8,661 +32%
1
2
3

PLSE Hedge Fund Activity: Q2 2020 in Review

51 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2020, worth a combined $30.3M — up 94% from $15.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PLSE positions and 4 closed out — a net gain of 4 holders — while 27 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.46M. The largest seller was Citadel Advisors, exiting entirely with an estimated $90K sold.

  • 51 institutional investors held Pulse Biosciences (PLSE) as of Q2 2020, up from 47 in Q1 2020.
  • Funds reported $30.3M of Pulse Biosciences stock for Q2 2020, up 94% quarter-over-quarter.
  • 8 funds opened new Pulse Biosciences positions in Q2 2020 and 4 closed out, a net change of +4 holders.
  • The largest Pulse Biosciences buyer in Q2 2020 was Vanguard Group, an estimated $1.46M added.
  • The largest Pulse Biosciences seller in Q2 2020 was Citadel Advisors, an estimated $90K sold.

Based on aggregated 13F filings for Q2 2020.